CPAP compliance. A CPAP prescription written is not a CPAP therapy delivered. Between the prescription and the clinical benefit sits a long, thin corridor called adherence, and the published data on how many patients successfully walk through that corridor is sobering. This article summarises the compliance evidence base — how the 4 hours per night,
counterfeit oxygen concentrators in India.The 2021 COVID-19 crisis flooded India with oxygen concentrators. Demand during April–June 2021 outstripped the licensed supply chain by an order of magnitude. The gap was filled by imports through non-standard channels, bulk-buying from unaudited Chinese OEMs, and a visible counterfeit segment that put “branded” stickers on unbranded units and pushed
COPD oxygen prescription in India.Long-term oxygen therapy remains one of only three interventions — alongside smoking cessation and, in selected patients, pulmonary rehabilitation or lung volume reduction — that extends survival in COPD. The evidence anchoring this is four decades old, the thresholds have not moved materially, and yet in Indian practice, LTOT prescription
An auto-titrating CPAP delivers pressure that varies breath-by-breath within a prescribed range, guided by the device’s detection of flow limitation, snoring, and apnea events. The same patient on the same night, running two different APAPs within the same pressure range, will experience different average pressure, different 95th-percentile pressure, different residual AHI, and different flow-limitation control.